ELVN
Enliven Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +7.7% ·
Aktienfluss +17.0% ·
neue Nettopositionen +7.1%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | +12 | 36.49M | $1.84B | +15 | −3 |
| Q1 2026 | 71 | +9 | 24.13M | $927.49M | +16 | −7 |
| Q4 2025 | 62 | -3 | 26.77M | $412.32M | — | −3 |
| Q3 2025 | 17 | 0 | 20.16M | $412.75M | — | — |
| Q2 2025 | 14 | +1 | 19.32M | $387.50M | +1 | — |
| Q1 2025 | 10 | +1 | 3.57M | $70.26M | +2 | −1 |
| Q4 2024 | 9 | 0 | 4.15M | $93.48M | — | — |
| Q3 2024 | 8 | +1 | 3.55M | $90.68M | +1 | — |
| Q2 2024 | 7 | — | 4.08M | $95.46M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 7.56M | — | $151.65M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 7.56M | — | $151.65M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 7.56M | — | $151.65M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passiv) | 2.97M | — | $59.52M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passiv) | 2.97M | — | $59.52M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 2.97M | — | $59.52M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 2.97M | — | $59.52M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 2.97M | — | $59.52M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 2.97M | — | $59.52M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 2.97M | — | $59.52M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 2.97M | — | $59.52M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passiv) | 2.97M | — | $59.52M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passiv) | 2.97M | — | $59.52M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passiv) | 2.97M | — | $59.52M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passiv) | 2.41M | — | $48.36M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passiv) | 2.41M | — | $48.36M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passiv) | 2.41M | — | $48.36M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passiv) | 2.41M | — | $48.36M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passiv) | 2.41M | — | $48.36M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 1.47M | +30.9% | $29.50M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 1.47M | +30.9% | $29.50M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | Point72 Asset Management ✦ | 1.35M | +867.0% | $27.14M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 23 | Geode Capital Management ✦ (passiv) | 882.75K | +7.8% | $17.71M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passiv) | 882.75K | +7.8% | $17.71M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | State Street Global Advisors ✦ (passiv) | 816.24K | +4.5% | $16.37M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 26 | T. Rowe Price ✦ | 528.25K | +3168.9% | $10.60M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 528.25K | +3168.9% | $10.60M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Duquesne Family Office ✦ | 463.00K | Neu | $9.29M | 0.2% | New | 1 | SEC ↗ |
| 29 | Marshall Wace ✦ | 333.33K | +2886.8% | $6.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Millennium Management ✦ | 318.45K | +139.6% | $6.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 31 | Adage Capital Partners ✦ | 96.00K | -78.7% | $1.93M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | Wellington Management ✦ | 94.01K | +11.0% | $1.89M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Wellington Management ✦ | 94.01K | +11.0% | $1.89M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 94.01K | +11.0% | $1.89M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Renaissance Technologies ✦ | 23.90K | +100.8% | $479,434 | 0.0% | ▲ Add | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Duquesne Family Office | $9.29M | 0.2% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 2.40K Anteile, $94,276 gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Officer · 3.90K Ant. · $227,650
Officer · 1.10K Ant. · $65,281
Officer · 4.63K Ant. · $270,168
Officer · 1.39K Ant. · $82,383
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik
9.5% der Klasse · Original-SEC-Einreichung anzeigen ↗
10.9% der Klasse · Original-SEC-Einreichung anzeigen ↗